158 related articles for article (PubMed ID: 17701343)
1. Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies.
Cui Y; Colsch B; Afonso C; Baumann N; Tabet JC; Mallet JM; Zhang Y
Glycoconj J; 2008 Feb; 25(2):147-55. PubMed ID: 17701343
[TBL] [Abstract][Full Text] [Related]
2. Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry.
Whitfield PD; Sharp PC; Johnson DW; Nelson P; Meikle PJ
Mol Genet Metab; 2001 May; 73(1):30-7. PubMed ID: 11350180
[TBL] [Abstract][Full Text] [Related]
3. Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.
Kuchař L; Asfaw B; Poupětová H; Honzíková J; Tureček F; Ledvinová J
Clin Chim Acta; 2013 Oct; 425():153-9. PubMed ID: 23838369
[TBL] [Abstract][Full Text] [Related]
4. Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity.
Molzer B; Sundt-Heller R; Kainz-Korschinsky M; Zobel M
Am J Med Genet; 1992 Nov; 44(4):523-6. PubMed ID: 1359786
[TBL] [Abstract][Full Text] [Related]
5. Urine sulfatides and the diagnosis of metachromatic leukodystrophy.
Natowicz MR; Prence EM; Chaturvedi P; Newburg DS
Clin Chem; 1996 Feb; 42(2):232-8. PubMed ID: 8595716
[TBL] [Abstract][Full Text] [Related]
6. Biochemical profiling to predict disease severity in metachromatic leukodystrophy.
Tan MA; Fuller M; Zabidi-Hussin ZA; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2010 Feb; 99(2):142-8. PubMed ID: 19815439
[TBL] [Abstract][Full Text] [Related]
7. HPLC analysis of urinary sulfatide: an aid in the diagnosis of metachromatic leukodystrophy.
Strasberg PM; Warren I; Skomorowski MA; Lowden JA
Clin Biochem; 1985 Apr; 18(2):92-7. PubMed ID: 2861921
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of arylsulfatase A deficiency in intact cultured cells using a fluorescent derivative of cerebroside sulfate.
Bach G; Dagan A; Herz B; Gatt S
Clin Genet; 1987 Apr; 31(4):211-7. PubMed ID: 2885115
[TBL] [Abstract][Full Text] [Related]
9. Metachromatic leukodystrophy and pseudoarylsulfatase A deficiency in a Danish family.
Tønnesen T; Bro PV; Brøndum Nielsen K; Lykkelund C
Acta Paediatr Scand; 1983 Mar; 72(2):175-8. PubMed ID: 6132516
[TBL] [Abstract][Full Text] [Related]
10. Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.
Matzner U; Breiden B; Schwarzmann G; Yaghootfam A; Fluharty AL; Hasilik A; Sandhoff K; Gieselmann V
J Biol Chem; 2009 Apr; 284(14):9372-81. PubMed ID: 19224915
[TBL] [Abstract][Full Text] [Related]
11. Sulfatide excreting heterozygous carrier of juvenile metachromatic leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy.
Harzer K; Recke AS
Humangenetik; 1975 Oct; 29(4):299-307. PubMed ID: 1176145
[TBL] [Abstract][Full Text] [Related]
12. Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry.
Barcenas M; Suhr TR; Scott CR; Turecek F; Gelb MH
Clin Chim Acta; 2014 Jun; 433():39-43. PubMed ID: 24370383
[TBL] [Abstract][Full Text] [Related]
13. Quantification of plasma sulfatides by mass spectrometry: Utility for metachromatic leukodystrophy.
Saville JT; Smith NJ; Fletcher JM; Fuller M
Anal Chim Acta; 2017 Feb; 955():79-85. PubMed ID: 28088283
[TBL] [Abstract][Full Text] [Related]
14. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
15. Sulfogalactosylceramides in motor and psycho-cognitive adult metachromatic leukodystrophy: relations between clinical, biochemical analysis and molecular aspects.
Colsch B; Afonso C; Turpin JC; Portoukalian J; Tabet JC; Baumann N
Biochim Biophys Acta; 2008 Mar; 1780(3):434-40. PubMed ID: 17980709
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic strategy of metachromatic leukodystrophy in Tunisia].
Barboura I; Chebel S; Ferchichi S; Ben Mansour R; Frih-Ayed M; Miled A
Ann Biol Clin (Paris); 2011; 69(4):465-9. PubMed ID: 21896413
[TBL] [Abstract][Full Text] [Related]
17. Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency allele.
Lugowska A; Tylki-Szymańska A; Berger J; Molzer B
Clin Biochem; 1997 Jun; 30(4):325-31. PubMed ID: 9209791
[TBL] [Abstract][Full Text] [Related]
18. Marked clinical difference between two sibs affected with juvenile metachromatic leukodystrophy.
Clarke JT; Skomorowski MA; Chang PL
Am J Med Genet; 1989 May; 33(1):10-3. PubMed ID: 2568751
[TBL] [Abstract][Full Text] [Related]
19. A variant form of metachromatic leukodystrophy without arylsulfatase deficiency.
Hahn AF; Gordon BA; Hinton GG; Gilbert JJ
Ann Neurol; 1982 Jul; 12(1):33-6. PubMed ID: 6126151
[TBL] [Abstract][Full Text] [Related]
20. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
